Sangamo Therapeutics
SGMO
#10615
Rank
ยฃ23.15 M
Marketcap
ยฃ0.05589
Share price
0.00%
Change (1 day)
-89.22%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -ยฃ82.12 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ34.55 Million. In 2025 the company made an earning of -ยฃ81.58 Million a decrease over its 2024 earnings that were of -ยฃ74.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ82.12 Million0.66%
2025 -ยฃ81.58 Million9.71%
2024 -ยฃ74.36 Million-17.27%
2023 -ยฃ89.88 Million-40.88%
2022 -ยฃ0.16 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ97.86 Million23.17%
2019 -ยฃ79.45 Million36.33%
2018 -ยฃ58.28 Million36.89%
2017 -ยฃ42.58 Million-22.32%
2016 -ยฃ54.81 Million54.86%
2015 -ยฃ35.4 Million75.62%
2014 -ยฃ20.16 Million0.13%
2013 -ยฃ20.13 Million
2011 -ยฃ27.06 Million43.66%
2010 -ยฃ18.84 Million28.52%
2009 -ยฃ14.66 Million-23.55%
2008 -ยฃ19.17 Million2.45%
2007 -ยฃ18.71 Million19.5%
2006 -ยฃ15.66 Million50.78%
2005 -ยฃ10.39 Million75%
2004 -ยฃ5.94 Million-33.25%
2003 -ยฃ8.89 Million-62.27%
2002 -ยฃ23.57 Million102.82%
2001 -ยฃ11.62 Million23.21%
2000 -ยฃ9.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.79 B-23,855.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ7.76 B-9,424.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ0.76 B-1,016.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ0.76 Billion 803.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-ยฃ1.48 Billion 1,672.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.80 B-7,070.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.84 B-1,119.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.11 B-235.16%๐Ÿ‡บ๐Ÿ‡ธ USA